For those interested, I'd recommend reading the transcript of the most recent c.c. The GHDX team is laying a solid foundation for future growth. The international footprint is great and OncoDx-for prostate will be a grand slam when traction takes hold. Great level to accumulate shares, when viewed in the context of the chart over the past 3 years. No quick turn around here. I'll add more if the price gets even better.